Skip to content

Relebactam

Published: July 26, 2026Updated: July 26, 2026

Relebactam is a beta-lactamase inhibitor combined with imipenem and cilastatin in the product RECARBRIO. This combination medication is used to treat complicated urinary tract infections and complicated intra-abdominal infections in adults. Relebactam protects imipenem from degradation by bacterial beta-lactamase enzymes, enhancing the antibiotic's effectiveness against resistant organisms.

Quick summary

RECARBRIO (imipenem/cilastatin/relebactam) is a combination antibiotic used for complicated urinary tract and intra-abdominal infections that works by inhibiting beta-lactamase enzymes to protect the carbapenem antibiotic.

Medically reviewed by WellAlly Editorial TeamLast reviewed July 26, 2026Editorial policy

Key facts at a glance

RxNorm
2184137
Generic
Relebactam
Class
unclassified
Brands
Recarbrio
Availability
rx
Lactation
unknown
Routes
—
Forms
injection
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Treatment of complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI) in adults caused by susceptible gram-negative bacteria, including Enterobacterales and Pseudomonas aeruginosa.

Relebactam is a beta-lactamase inhibitor that protects imipenem (a carbapenem antibiotic) from degradation by serine beta-lactamases. Cilastatin inhibits renal dehydropeptidase, preventing metabolism of imipenem in the kidneys.

Not effective against gram-positive bacteria or anaerobic bacteria alone; use requires susceptibility testing. Contraindicated in patients with history of anaphylaxis to beta-lactams. Monitor for seizures and Clostridioides difficile-associated diarrhea. Dose adjustment needed for renal impairment.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy